213 related articles for article (PubMed ID: 28900036)
21. Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer.
Yamamoto Y; Matsuyama H; Kawauchi S; Matsumoto H; Nagao K; Ohmi C; Sakano S; Furuya T; Oga A; Naito K; Sasaki K
Oncology; 2006; 70(3):231-7. PubMed ID: 16837776
[TBL] [Abstract][Full Text] [Related]
22. Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage.
Lee JH; Xu B; Lee CH; Ahn JY; Song MS; Lee H; Canman CE; Lee JS; Kastan MB; Lim DS
Mol Cancer Res; 2003 Jul; 1(9):674-81. PubMed ID: 12861053
[TBL] [Abstract][Full Text] [Related]
23. Polo-like kinase 1 (PLK1) and protein phosphatase 6 (PP6) regulate DNA-dependent protein kinase catalytic subunit (DNA-PKcs) phosphorylation in mitosis.
Douglas P; Ye R; Trinkle-Mulcahy L; Neal JA; De Wever V; Morrice NA; Meek K; Lees-Miller SP
Biosci Rep; 2014 Jun; 34(3):. PubMed ID: 24844881
[TBL] [Abstract][Full Text] [Related]
24. A PIM-CHK1 signaling pathway regulates PLK1 phosphorylation and function during mitosis.
Adam K; Cartel M; Lambert M; David L; Yuan L; Besson A; Mayeux P; Manenti S; Didier C
J Cell Sci; 2018 Aug; 131(15):. PubMed ID: 29976560
[TBL] [Abstract][Full Text] [Related]
25. Polo-like kinase 1 (PLK1) signaling in cancer and beyond.
Iliaki S; Beyaert R; Afonina IS
Biochem Pharmacol; 2021 Nov; 193():114747. PubMed ID: 34454931
[TBL] [Abstract][Full Text] [Related]
26. Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.
Wang Y; Wu L; Yao Y; Lu G; Xu L; Zhou J
Cancer Lett; 2018 Nov; 436():1-9. PubMed ID: 30118839
[TBL] [Abstract][Full Text] [Related]
27. Ectopic expression of Plk1 leads to activation of the spindle checkpoint.
Tang J; Erikson RL; Liu X
Cell Cycle; 2006 Nov; 5(21):2484-8. PubMed ID: 17102638
[TBL] [Abstract][Full Text] [Related]
28. Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.
Li H; Wang Y; Liu X
J Biol Chem; 2008 Mar; 283(10):6209-21. PubMed ID: 18171681
[TBL] [Abstract][Full Text] [Related]
29. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Polo-like kinase-1 by DNA damage occurs in an ATM- or ATR-dependent fashion.
van Vugt MA; Smits VA; Klompmaker R; Medema RH
J Biol Chem; 2001 Nov; 276(45):41656-60. PubMed ID: 11514540
[TBL] [Abstract][Full Text] [Related]
31. The Plk1 Polo box domain mediates a cell cycle and DNA damage regulated interaction with Chk2.
Tsvetkov LM; Tsekova RT; Xu X; Stern DF
Cell Cycle; 2005 Apr; 4(4):609-17. PubMed ID: 15876876
[TBL] [Abstract][Full Text] [Related]
32. Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR.
Shtivelman E
Mol Cancer Res; 2003 Nov; 1(13):959-69. PubMed ID: 14638868
[TBL] [Abstract][Full Text] [Related]
33. Chk2-dependent phosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) regulates centrosome maturation.
Nai S; Shi Y; Ru H; Ding Y; Geng Q; Li Z; Dong MQ; Xu X; Li J
Cell Cycle; 2019 Oct; 18(20):2651-2659. PubMed ID: 31416392
[TBL] [Abstract][Full Text] [Related]
34. Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals.
Guan R; Tapang P; Leverson JD; Albert D; Giranda VL; Luo Y
Cancer Res; 2005 Apr; 65(7):2698-704. PubMed ID: 15805268
[TBL] [Abstract][Full Text] [Related]
35. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
[TBL] [Abstract][Full Text] [Related]
36. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
[TBL] [Abstract][Full Text] [Related]
37. Heterologous expression of mammalian Plk1 in Drosophila reveals divergence from Polo during late mitosis.
Pearson J; Godinho SA; Tavares A; Glover DM
Exp Cell Res; 2006 Apr; 312(6):770-81. PubMed ID: 16412419
[TBL] [Abstract][Full Text] [Related]
38. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
Zhou Q; Bai M; Su Y
Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
[TBL] [Abstract][Full Text] [Related]
39. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
[TBL] [Abstract][Full Text] [Related]
40. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.
Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT
Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
